Wells Fargo Downgrades Amrize to Equal-Weight, Lowers Price Target to $44
Wells Fargo analyst Timna Tanners downgrades Amrize (NYSE:AMRZ) from Overweight to Equal-Weight and lowers the price target from $55 to $44.
A big bank's expert just said Amrize stock looks less promising than before, lowering their guess of what it should be worth. When important analysts become less excited about a company, it's worth paying attention to why they changed their mind.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.